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Abstract
Background: In age-matched cohorts of screening study participants recruited from primary care
clinics, mean serum transferrin saturation values were significantly lower and mean serum ferritin
concentrations were significantly higher in Native Americans than in whites. Twenty-eight percent
of 80 Alabama white hemochromatosis probands with HFE  C282Y homozygosity previously
reported having Native American ancestry, but the possible effect of this ancestry on
hemochromatosis phenotypes was unknown.
Methods: We compiled observations in these 80 probands and used univariate and multivariate
methods to analyze associations of age, sex, Native American ancestry (as a dichotomous variable),
report of ethanol consumption (as a dichotomous variable), percentage transferrin saturation and
loge serum ferritin concentration at diagnosis, quantities of iron removed by phlebotomy to achieve
iron depletion, and quantities of excess iron removed by phlebotomy.
Results: In a univariate analysis in which probands were grouped by sex, there were no significant
differences in reports of ethanol consumption, transferrin saturation, loge  serum ferritin
concentration, quantities of iron removed to achieve iron depletion, and quantities of excess iron
removed by phlebotomy in probands who reported Native American ancestry than in those who
did not. In multivariate analyses, transferrin saturation (as a dependent variable) was not
significantly associated with any of the available variables, including reports of Native American
ancestry and ethanol consumption. The independent variable quantities of excess iron removed by
phlebotomy was significantly associated with loge serum ferritin used as a dependent variable (p <
0.0001), but not with reports of Native American ancestry or reports of ethanol consumption. Loge
serum ferritin was the only independent variable significantly associated with quantities of excess
iron removed by phlebotomy used as a dependent variable (p < 0.0001) (p < 0.0001; ANOVA of
regression).
Conclusion: We conclude that the iron-related phenotypes of hemochromatosis probands with
HFE C282Y homozygosity are similar in those with and without Native American ancestry reports.
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Background
Hemochromatosis associated with homozygosity for HFE
C282Y on Ch6p occurs predominantly in whites of west-
ern European descent, although the iron-related pheno-
types of persons with this type of hemochromatosis are
variable. Some C282Y homozygotes, especially those
diagnosed in medical care, have serum ferritin >1000 ng/
mL, hepatic cirrhosis, and severe iron overload proven by
measurement of hepatic iron concentration or phlebot-
omy to achieve iron depletion [1,2]. Other C282Y
homozygotes, particularly those diagnosed in screening
programs, have little or no target organ injury or iron
overload [3-6]. Mutations in iron-related genes other than
HFE appear to account for severe iron overload in some
C282Y homozygotes [7-9]. However, the overall variabil-
ity of iron-related phenotypes in C282Y homozygotes
remains unexplained by differences in dietary factors
[10,11] or mutations in known iron-related genes [12-
20].
Results of the HEIRS Study reveal that there are small but
significant differences between the iron-related screening
phenotypes of Native American and those of white partic-
ipants recruited from primary care settings who did not
report a previous diagnosis of hemochromatosis or iron
overload [21]. In age-matched cohorts, mean serum trans-
ferrin saturation values were significantly lower and mean
serum ferritin concentrations were significantly higher in
Native Americans than in whites [21]. In these partici-
pants, multiple regression analyses revealed that sex, race/
ethnicity, and HFE genotype were significant independent
determinants of TfSat evaluated as a continuous depend-
ent variable; sex, age, and HFE genotype were significant
independent determinants of SF evaluated as a continu-
ous dependent variable [21]. In a different study, twenty-
eight percent of 80 white hemochromatosis probands
with HFE C282Y homozygosity diagnosed in medical care
in Alabama reported that they had one or more grandpar-
ents who were Native Americans [22]. Thus, we evaluated
the effect of Native American ancestry on the iron-related
hemochromatosis phenotypes of these 80 Alabama
hemochromatosis probands [22]. We defined iron-related
phenotypes as transferrin saturation at diagnosis, loge
serum ferritin concentration at diagnosis, and quantities
of excess iron removed by phlebotomy.
Methods
General criteria for selection of study subjects
The performance of this work was approved by the Insti-
tutional Review Boards of Brookwood Medical Center and
the University of Alabama at Birmingham. All subjects
were adults (≥18 years of age) who resided in central Ala-
bama; each identified himself/herself as white. Hemo-
chromatosis probands with HFE  C282Y homozygosity
were diagnosed in routine medical care during the interval
1992 – 2002, but were otherwise unselected [22]. None of
the present probands were identified by general popula-
tion screening or systematic screening of clinic popula-
tions. We tabulated observations in the 80 probands who
previously reported evaluable country of ancestry infor-
mation [22]. We excluded persons of sub-Saharan African
or African American descent because 1) HFE mutations
are uncommon among African Americans in central Ala-
bama [3,23]; and 2) the iron-related phenotypes and gen-
otypes of most African Americans with iron overload are
dissimilar to those of white persons with hemochromato-
sis in Alabama [24,25].
Diagnosis of hemochromatosis and evaluation of iron 
overload
A presumptive diagnosis of hemochromatosis was based
on demonstration of a phenotype defined by persistently
elevated transferrin saturation (>60% in men, >50% in
women) [2,26,27]. Evaluation for iron overload and its
complications were performed as described elsewhere
[2,26,27].
We defined "excess iron removed by phlebotomy" as the
difference of iron removed by phlebotomy to achieve iron
depletion and the estimated quantity of iron absorbed
during the period of phlebotomy to achieve iron deple-
tion. We estimated daily iron absorption in these patients
using these assumptions: 1) the age of onset of increased
iron absorption was defined as 12 years, because excess
iron absorption likely begins in adolescence or early
adulthood in C282Y homozygotes [28]; 2) the average
patient in the present study had phlebotomy on alternate
weeks [29]; 3) daily iron absorption was the same from
age 12 years until iron depletion was achieved by phlebot-
omy; and 4) each year consists of 365 days. These esti-
mates do not include allowances for growth and
development, menstrual blood loss, childbirth, lactation,
surgical or laboratory blood losses, blood donation, die-
tary preferences, or other factors.
Food intake recall or other dietary reports were not avail-
able in the present cases.
Determination of ancestry
Questionnaire and interview design to obtain data on
countries of ancestry and to permit estimation of frequen-
cies of countries of ancestry reports are described else-
where [22]. This permitted computation of individual
country of ancestry scores which reflect proportional or
percentage national ancestry, including Native American
ancestry [22].
Ethanol consumption
We reviewed charts on each of the patients in the present
study, and tabulated their self-reports of daily ethanolBMC Medical Genetics 2006, 7:22 http://www.biomedcentral.com/1471-2350/7/22
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consumption. We categorized these in this manner: non-
drinkers (reported consuming no ethanol); moderate
drinkers (reported ethanol consumption estimated at <30
g daily); and heavy drinkers (reported ethanol consump-
tion estimated at ≥30 g daily). Because some proband sub-
groups based on reports of ethanol consumption were
very small, we analyzed these data as dichotomous varia-
bles (non-drinkers or drinkers) in multivariate analyses.
Iron-associated measurements
Serum iron concentration, total serum iron-binding
capacity, and serum ferritin concentration were measured
at diagnosis using routine automated methods and blood
specimens obtained after an overnight fast. Transferrin
saturation was expressed as the quotient of serum iron
and iron-binding capacity × 100%. In some cases, percu-
taneous biopsy specimens of liver were obtained as an
adjunct to hemochromatosis diagnosis and evaluation of
hepatic pathology. Phlebotomy to induce iron depletion
was performed as previously described; one unit of phle-
botomy was defined as ~500 mL of blood and 200 mg of
iron [26]. Iron overload was defined by a) elevation of
serum ferritin concentration (≥300 ng/mL in males, ≥200
ng/mL in females) without other explanation; b) 3+ or 4+
intrahepatocytic iron visualized using Perls' staining; c)
hepatic iron index ≥1.9; or 4) removal of ≥2.0 g Fe by ther-
apeutic phlebotomy [30]. Iron depletion was defined as
complete when the serum ferritin level was 10 – 20 ng/mL
[26].
HFE mutation analyses
HFE  mutation analyses using genomic DNA obtained
from buffy coat were performed as described previously
[27].
Statistical considerations
The dataset consisted of observations on 80 evaluable
hemochromatosis probands with HFE C282Y homozy-
gosity [22]. Observations on age, sex, report or no report
of Native American ancestry, transferrin saturation, and
serum ferritin at diagnosis, and the units of phlebotomy
to achieve iron depletion were available in each proband.
A computer spreadsheet (Excel 2000, Microsoft Corp.,
Redmond, WA) and a statistical program (GB-Stat, v. 8.0
2000, Dynamic Microsystems, Inc., Silver Spring, MD)
were used to perform the present analyses. Serum ferritin
measurements were normalized by natural logarithmic
(loge) transformation for analysis [31]. We used separate
multiple regression models to examine transferrin satura-
tion, loge serum ferritin, and quantities of excess iron
removed by phlebotomy as dependent variables (with
each as independent variables in models for the other
two). Age, transferrin saturation, loge serum ferritin, and
quantities of excess iron removed by phlebotomy were
evaluated as continuous variables; units of phlebotomy to
achieve iron depletion was evaluated in univariate analy-
ses only. Sex, Native American ancestry, and reports of
ethanol consumption were evaluated as dichotomous var-
iables. Most descriptive data are displayed as enumera-
tions, percentages, mean ± 1 standard deviation (SD), or
antilogs of mean loge-transformed SF data (95% confi-
dence intervals (95% CI)), or ranges. Age and iron-related
phenotype data were rounded to the nearest integer for
presentation. Frequency data were compared using Pear-
son Chi-square tests or Fisher's exact test, as appropriate.
Means were compared using Student's t-test (two-tail).
Correlation matrices with Bonferroni correction were
used to evaluate the relationships of multiple variables.
Multiple regression models were also used to evaluate the
relationships of the variables age, sex, Native American
ancestry, transferrin saturation, loge serum ferritin at diag-
nosis, and units of phlebotomy to achieve iron depletion.
Accuracy of the regression models was estimated using
analysis of variance (ANOVA). Values of p < 0.05 were
defined as significant.
Results
General characteristics of hemochromatosis probands
There were reports from 80 evaluable probands (47 men,
33 women) [22]. At diagnosis, their mean age at diagnosis
was 51 ± 14 years (range 18 – 78 years). Iron overload was
present in 47 men and 31 women. Sixteen percent had
hepatic cirrhosis demonstrated by biopsy, 16% had
arthropathy typical of hemochromatosis, 19% had diabe-
tes mellitus, and none had cardiomyopathy. Fifteen per-
cent of men had hypogonadotrophic hypogonadism.
The mean ages of men and women were similar (52 ± 15
years vs. 51 ± 12 years; p = 0.2204). Native American
ancestry was reported by 10 men (21.3%) and 12 women
(36.4%) (p = 0.1368, Chi-square test). Mean transferrin
saturation was significantly higher in men than in women
(85 ± 13% vs. 77 ± 19%; p = 0.0105). The mean serum fer-
ritin concentration was significantly greater in men than
in women (1062 ng/mL (95% CI: 770, 1464) vs. 433 ng/
mL (95% CI: 302, 620)) (p = 0.0003). The mean units of
phlebotomy required to achieve iron depletion in men
was significantly greater than in women (35 ± 33 units vs.
20 ± 21 units; p = 0.0210). The mean quantity of excess
iron removed by phlebotomy was significantly greater in
men than in women (6534 ± 5578 mg vs. 3750 ± 3744
mg, respectively; p = 0.0162).
Ethanol consumption
Self-reports of ethanol consumption in the present sub-
jects are displayed in Table 2. The frequencies of non-
drinkers and drinkers were similar in men with or without
Native American ancestry (p = 0.3659; Fisher's exact test),
and in women with or without Native American ancestry
(p = 0.3474; Fisher's exact test). However, self-reports ofBMC Medical Genetics 2006, 7:22 http://www.biomedcentral.com/1471-2350/7/22
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ethanol consumption were significantly greater in all 47
men than in all 33 women (p = 0.0218; Chi-square anal-
ysis). Ten men (21.3%) reported that they consumed ≥30
g of ethanol daily; one woman (3.0%) reported she con-
sumed ≥30 g of ethanol daily (p = 0.0180; Fisher's exact
test).
Univariate analyses of phenotypes with and without 
reports of Native American ancestry
In probands grouped by sex, mean ages at diagnosis,
transferrin saturation values, loge serum ferritin concen-
trations, units of phlebotomy to achieve iron depletion,
and mean quantities of excess iron removed by phlebot-
omy were not significantly different in those who reported
Native American ancestry and in those who did not report
Native American ancestry (Table 1).
Correlation of phenotype data and reports of Native 
American ancestry
A correlation matrix with Bonferroni correction was used
to evaluate relationships of age, sex, report (or no report)
of Native American ancestry, report (or no report) of eth-
anol consumption, transferrin saturation, loge serum ferri-
tin concentration, and quantities of excess iron removed
by phlebotomy. There was no significant correlation of
Native American ancestry reports and other variables.
There were significant correlations of loge serum ferritin
concentration with a) male sex (p < 0.01) and b) quanti-
ties of excess iron removed by phlebotomy (p < 0.01).
Multiple regression analyses of transferrin saturation
Straight regression was used to evaluate percentage trans-
ferrin saturation as a dependent variable. The p values
associated with the available independent variables were:
age, 0.0818; sex, 0.3382; report of Native American ances-
try, 0.1082; report of ethanol consumption, 0.8770; loge
serum ferritin concentration, 0.0520; and quantities of
excess iron removed by phlebotomy, 0.3655. ANOVA of
this regression yielded p = 0.0675. Forward stepwise
regression analysis was performed to determine if any of
the available independent phenotype variables were use-
ful in this model. No independent variable was signifi-
cantly associated with percentage transferrin saturation,
including Native American ancestry (p = 0.1082).
Multiple regression analyses of serum ferritin 
concentrations
Straight regression was used to evaluate loge serum ferritin
as a dependent variable. The p values associated with the
available independent variables were: age at diagnosis,
0.1122; male sex, 0.0608; report of Native American
ancestry, 0.2537; report of ethanol consumption, 0.4959;
serum transferrin saturation, 0.0520; and quantities of
excess iron removed by phlebotomy, <0.0001. ANOVA of
this regression yielded p < 0.0001. In forward stepwise
regression analyses, the only independent variable signif-
icantly associated with loge serum ferritin was quantities
of excess iron removed by phlebotomy (p < 0.0001).
Multiple regression analyses of quantities of excess iron 
removed by phlebotomy
Straight regression was used to evaluate quantities of
excess iron removed by phlebotomy as a dependent vari-
able. Forward stepwise regression analysis was used to
determine which of the available independent phenotype
variables were useful in this model. Regardless of the addi-
tion of other independent variables to the model, loge
serum ferritin was the only independent variable signifi-
cantly associated with quantities of excess iron removed
by phlebotomy (p < 0.0001 for all combinations of the
available independent variables) (p < 0.0001, ANOVA of
Table 1: Characteristics of Alabama hemochromatosis probands with HFE C282Y homozygosity1
Characteristic Age, y Transferrin 
saturation, %
Serum ferritin, 
ng/mL
Iron removed to 
achieve iron 
depletion, mg
Excess iron 
removed by 
phlebotomy, mg3
Men with report of Native American ancestry (n = 10)2 46 ± 10 84 ± 15 1348 (538, 
3380)
7250 ± 5082 6827 ± 4701
Men without report of Native American ancestry (n = 37) 53 ± 16 85 ± 12 992 (700, 1404) 6962 ± 6829 6484 ± 5773
Value of p 0.1532 0.8966 0.4988 0.9156 0.8917
Women with report of Native American ancestry (n = 12)2 48 ± 10 71 ± 20 465 (198, 1093) 5066 ± 5398 4660 ± 4640
Women without report of Native American ancestry (n = 21) 53 ± 13 80 ± 18 415 (288, 598) 3378 ± 3444 3271 ± 3215
Value of p 0.2948 0.2251 0.4194 0.4194 0.4402
1Age, transferrin saturation at diagnosis, and units of phlebotomy to achieve iron depletion data are displayed as mean ± 1 standard deviation (SD). 
Serum ferritin concentrations at diagnosis are displayed as mean (95% confidence intervals) of antilogs of loge-transformed measurements. 
Comparisons of mean variables of respective subgroups of men and women were made using univariate technique (two-tail Student t-test).
2The mean proportion of Native American ancestry (± 1 SD) estimated as previously described [22] was 24.3 ± 11.9 in men and 32.3 ± 22.9 in 
women (p = 0.3119).
3These data were computed using quantities of iron removed by phlebotomy to achieve iron depletion, and the assumptions described in Methods, 
Diagnosis of hemochromatosis and evaluation of iron overload.BMC Medical Genetics 2006, 7:22 http://www.biomedcentral.com/1471-2350/7/22
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regression, for all combinations of the available inde-
pendent variables).
Discussion
Native American ancestry was not associated with signifi-
cantly lower mean transferrin saturation percentages in
hemochromatosis probands with HFE C282Y homozy-
gosity than in probands without Native American ances-
try. The multivariate model did not reveal a significant
statistical association of transferrin saturation with Native
American ancestry or other available independent varia-
bles. In the HEIRS Study, mean values of transferrin satu-
ration were significantly lower in participants grouped by
sex who reported that they were Native Americans than in
whites, although the absolute differences in the mean
transferrin saturation values between these two race/eth-
nicity groups were small [21]. There were no significant
differences in mean transferrin saturation values in Native
Americans and whites grouped by sex who had neither
HFE C282Y nor HFE H63D [21].
Native American ancestry was not associated with signifi-
cantly greater loge serum ferritin concentration in hemo-
chromatosis probands with HFE  C282Y homozygosity
than we observed in probands without Native American
ancestry reports. The multivariate model did not reveal a
significant statistical association of log serum ferritin con-
centration with Native American ancestry or other availa-
ble independent variables. In the HEIRS Study, mean
values of loge serum ferritin concentration were signifi-
cantly higher in participants grouped by sex who reported
that they were Native Americans than in whites, although
these absolute differences were also small [21]. There were
no significant differences in mean serum ferritin values in
Native Americans and whites grouped by sex who had nei-
ther C282Y nor H63D [21].
Quantity of excess iron removed by phlebotomy was the
only significant independent variable associated with loge
serum ferritin concentration in the present study. This is
consistent with previous analyses that reveal significant
positive relationships of units of phlebotomy or quanti-
ties of iron removed to achieve iron depletion in HFE
C282Y homozygotes [32,33]. Although elevated serum
ferritin concentrations sometimes occur in association
with or as a consequence of ethanol consumption
[34,35], we observed no significant association of loge
serum ferritin concentration (or quantities of excess iron
removed by phlebotomy) with reports of ethanol con-
sumption in the present study.
There are uncertainties in the present study. The overall
number of probands available for analysis was small, and
thus evaluation of greater numbers of probands may have
revealed significant differences not detected herein. The
proportional Native American ancestry reported by some
of the present probands was low [22]. This could explain
the similarity of the iron-related phenotypes in probands
with or without Native American ancestry reports. The
Native American ancestry reported by the present
probands was predominantly Cherokee or Creek heritage
[22], consistent with accounts of early Alabama history
[36-39] and with U.S. Census data on Alabama since 1820
[40-42]. However, there are no reports of the effect of
ancestry derived in part from subgroups of Native Ameri-
cans typical of regions other than Alabama on iron-related
phenotypes in HFE  C282Y homozygotes. We did not
examine effects of Native American ancestry on possible
non-biochemical expression of hemochromatosis and
iron overload in the present subjects. Although 98% of
the present subjects had iron overload, the proportions of
these patients who had hepatic cirrhosis demonstrated by
biopsy, arthropathy typical of hemochromatosis, diabetes
mellitus, cardiomyopathy, or hypogonadotrophic hypog-
onadism were low. In addition, the occurrence of these
complications of iron overload in persons with hemo-
chromatosis is, in general, related to the severity of iron
overload [43]. However, we observed no significant differ-
ences in quantities of excess iron removed by phlebotomy
as a function of race/ethnicity in the present analyses.
Thus, it is unlikely that there were significant differences
in clinical complications of iron overload in the present
patients that could be attributed to reports of Native
American ancestry, although this is unproven. Iron-
related phenotypes are also influenced by common liver
disorders [34,35,44-47], body mass index [48,49], and
rates of menstrual blood loss [50], although most of the
subjects evaluated in these reports were not Native Amer-
icans. Further, evaluation of these variables was beyond
the scope of the present study.
Table 2: Self-reports of ethanol consumption of Alabama hemochromatosis probands with HFE C282Y homozygosity1
Characteristic No ethanol consumption, n (%) Ethanol consumption, n (%)
Men with report of Native American ancestry (n = 10) 5 (50.0) 5 (50.0)
Men without report of Native American ancestry (n = 37) 14 (37.8) 23 (62.2)
Women with report of Native American ancestry (n = 12) 7 (58.3) 5 (41.7)
Women without report of Native American ancestry (n = 21) 15 (71.4) 6 (28.6)BMC Medical Genetics 2006, 7:22 http://www.biomedcentral.com/1471-2350/7/22
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Conclusion
We conclude that the iron-related phenotypes of hemo-
chromatosis probands with HFE C282Y homozygosity are
similar in those with and without Native American ances-
try reports. The present results suggest that the occurrence
of Native American ancestry in whites would not signifi-
cantly affect outcomes of hemochromatosis diagnosis and
screening with transferrin saturation or serum ferritin
measurements. This is consistent with previous observa-
tions that the percentage of Native American ancestry
reports and the proportional Native American ancestry of
the present probands were similar to those of white con-
trol subjects who resided in central Alabama [22]. The
transferrin saturation phenotype screening of two Native
American populations in Canada (1407 "Native Ameri-
cans," 310 Inuit) revealed no subject with evidence of iron
overload [51]. This is consistent with HEIRS Study reports
that the frequency of the C282Y allele is low in Native
Americans [3,21], and that none of 645 HEIRS Study par-
ticipants who reported that they were Native Americans
had HFE C282Y homozygosity [21].
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
JCB conceived and designed the study, diagnosed and
treated the hemochromatosis probands and compiled
their clinical data, performed some of the statistical anal-
yses, and contributed to writing the manuscript. EHB
compiled country of ancestry data, performed some of the
statistical analyses, and contributed to writing the manu-
script. RTA compiled data on hemochromatosis
probands, performed HFE  typing of many of the
probands, and contributed to writing the manuscript. All
authors approved of the manuscript in its final form.
Acknowledgements
This work was supported in part by Southern Iron Disorders Center and 
the Immunogenetics Program.
References
1. Deugnier Y, Jouanolle AM, Chaperon J, Moirand R, Pithois C, Meyer
JF, Pouchard M, Lafraise B, Brigand A, Caserio-Schoenemann C,
Mosser J, Adams P, le Gall JY, David V: Gender-specific pheno-
typic expression and screening strategies in C282Y-linked
haemochromatosis: a study of 9396 French people.  Br J Hae-
matol 2002, 118:1170-1178.
2. Barton JC, Barton NH, Alford TJ: Diagnosis of hemochromatosis
probands in a community hospital.  Am J Med 1997,
103:498-503.
3. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH,
McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leien-
decker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E,
Sholinsky P: Hemochromatosis and iron-overload screening in
a racially diverse population.  N Engl J Med 2005, 352:1769-1778.
4. Asberg A, Hveem K, Thorstensen K, Ellekjter E, Kannelonning K,
Fjosne U, Halvorsen TB, Smethurst HB, Sagen E, Bjerve KS: Screen-
ing for hemochromatosis: high prevalence and low morbid-
ity in an unselected population of 65,238 persons.  Scand J
Gastroenterol 2001, 36:1108-1115.
5. Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E: Penetrance of
hemochromatosis.  Blood Cells Mol Dis 2002, 29:418-432.
6. Waalen J, Nordestgaard BG, Beutler E: The penetrance of hered-
itary hemochromatosis.  Best Pract Res Clin Haematol 2005,
18:203-220.
7. Jacolot S, Le Gac G, Scotet V, Quere I, Mura C, Ferec C: HAMP as
a modifier gene that increases the phenotypic expression of
the HFE pC282Y homozygous genotype.  Blood 2004,
103:2835-2840.
8. Le Gac G, Scotet V, Ka C, Gourlaouen I, Bryckaert L, Jacolot S, Mura
C, Ferec C: The recently identified type 2A juvenile haemo-
chromatosis gene (HJV), a second candidate modifier of the
C282Y homozygous phenotype.  Hum Mol Genet 2004,
13:1913-1918.
9. Merryweather-Clarke AT, Cadet E, Bomford A, Capron D, Viprakasit
V, Miller A, McHugh PJ, Chapman RW, Pointon JJ, Wimhurst VL, Live-
sey KJ, Tanphaichitr V, Rochette J, Robson KJ: Digenic inheritance
of mutations in HAMP and HFE results in different types of
haemochromatosis.  Hum Mol Genet 2003, 12:2241-2247.
10. Cook JD: Hemochromatosis: effect of iron fortification of
foods.  In Hemochromatosis: genetics, pathophysiology, diagnosis and
treatment Edited by: Barton JC and Edwards CQ. Cambridge, Cam-
bridge University Press; 2000:535-543. 
11. Chan AT, Ma J, Tranah GJ, Giovannucci EL, Rifai N, Hunter DJ, Fuchs
CS: Hemochromatosis gene mutations, body iron stores, die-
tary iron, and risk of colorectal adenoma in women.  J Natl
Cancer Inst 2005, 97:917-926.
12. Carter K, Bowen DJ, McCune CA, Worwood M: Haptoglobin type
neither influences iron accumulation in normal subjects nor
predicts clinical presentation in HFE C282Y haemochroma-
tosis: phenotype and genotype analysis.  Br J Haematol 2003,
122:326-332.
13. Beutler E, Gelbart T, Lee P: Haptoglobin polymorphism and iron
homeostasis.  Clin Chem 2002, 48:2232-2235.
14. Barton JC, Wiener HW, Acton RT, Go RC: HLA haplotype A*03-
B*07 in hemochromatosis probands with HFE C282Y
homozygosity: frequency disparity in men and women and
lack of association with severity of iron overload.  Blood Cells
Mol Dis 2005, 34:38-47.
15. Beutler E, Beutler L, Lee PL, Barton JC: The mitochondrial nt
16189 polymorphism and hereditary hemochromatosis.
Blood Cells Mol Dis 2004, 33:344-345.
16. Beutler E, Gelbart T: Tumor necrosis factor alpha promoter
polymorphisms and liver abnormalities of homozygotes for
the 845G>A(C282Y) hereditary hemochromatosis muta-
tion.  Blood 2002, 100:2268-2269.
17. Lee PL, Ho NJ, Olson R, Beutler E: The effect of transferrin pol-
ymorphisms on iron metabolism.  Blood Cells Mol Dis 1999,
25:374-379.
18. Lee PL, Gelbart T, West C, Halloran C, Felitti V, Beutler E: A study
of genes that may modulate the expression of hereditary
hemochromatosis: transferrin receptor-1, ferroportin, ceru-
loplasmin, ferritin light and heavy chains, iron regulatory
proteins (IRP)-1 and -2, and hepcidin.  Blood Cells Mol Dis 2001,
27:783-802.
19. Lee PL, Barton JC, Brandhagen D, Beutler E: Hemojuvelin (HJV)
mutations in persons of European, African-American and
Asian ancestry with adult onset haemochromatosis.  Br J Hae-
matol 2004, 127:224-229.
20. Tsuchihashi Z, Hansen SL, Quintana L, Kronmal GS, Mapa FA, Feder
JN, Wolff RK: Transferrin receptor mutation analysis in
hereditary hemochromatosis patients.  Blood Cells Mol Dis 1998,
24:317-321.
21. Barton JC, Acton RT, Lovato L, Speechley MR, McLaren CE, Harris
EL, Reboussin DM, Adams PC, Dawkins FW, Gordeuk VR, Walker
AP: Initial Screening Transferrin Saturation Values, Serum
Ferritin Concentrations, and HFE Genotypes in Native
Americans and Whites in the Hemochromatosis and Iron
Overload Screening (HEIRS) Study.  Clin Genet 2006, 69:48.
22. Barton EH, Barton JC, Hollowell WW, Acton RT: Countries of
ancestry reported by hemochromatosis probands and con-
trol subjects in central Alabama.  Ethnicity and Disease 2004,
14:73-81.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Medical Genetics 2006, 7:22 http://www.biomedcentral.com/1471-2350/7/22
Page 7 of 7
(page number not for citation purposes)
23. Barton JC, Acton RT: Inheritance of two HFE mutations in Afri-
can Americans: cases with hemochromatosis phenotypes
and estimates of hemochromatosis phenotype frequency.
Genetics in Medicine 2001, 3:294-300.
24. Barton JC, Edwards CQ, Bertoli LF, Shroyer TW, Hudson SL: Iron
overload in African Americans.  American Journal of Medicine
1995, 99:616-623.
25. Barton JC, Acton RT, Rivers CA, Bertoli LF, Gelbart T, West C, Beut-
ler E: Genotypic and phenotypic heterogeneity of African
Americans with primary iron overload.  Blood Cells Mol Dis 2003,
31:310-319.
26. Barton JC, McDonnell SM, Adams PC, Brissot P, Powell LW, Edwards
CQ, Cook JD, Kowdley KV, Group HMW: Management of hemo-
chromatosis.  Ann Intern Med 1998, 129:932-939 [http://
PM:9867745].
27. Barton JC, Shih WW, Sawada-Hirai R, Acton RT, Harmon L, Rivers
C, Rothenberg BE: Genetic and clinical description of hemo-
chromatosis probands and heterozygotes: evidence that
multiple genes linked to the major histocompatibility com-
plex are responsible for hemochromatosis.  Blood Cells Mol Dis
1997, 23:135-145.
28. Barton JC, Felitti VJ, Lee P, Beutler E: Characteristics of HFE
C282Y homozygotes younger than age 30 years.  Acta Haema-
tol 2004, 112:219-221.
29. Hicken BL, Tucker DC, Barton JC: Patient compliance with phle-
botomy therapy for iron overload associated with hemo-
chromatosis.  Am J Gastroenterol 2003, 98:2072-2077.
30. McLaren CE, Barton JC, Adams PC, Harris EL, Acton RT, Press N,
Reboussin DM, McLaren GD, Sholinsky P, Walker AP, Gordeuk VR,
Leiendecker-Foster C, Dawkins FW, Eckfeldt JH, Mellen BG, Speech-
ley M, Thomson E: Hemochromatosis and Iron Overload
Screening (HEIRS) study design for an evaluation of 100,000
primary care-based adults.  Am J Med Sci 2003, 325:53-62.
31. Box GEP, Cox DR: An analysis of transformations.  J Royal Stat
Soc Series B (Methodological) 1964, 26:211-252.
32. Phatak PD, Barton JC: Phlebotomy-mobilized iron as a surro-
gate for liver iron content in hemochromatosis patients.
Hematology 2003, 8:429-432.
33. Beutler E, Felitti V, Ho NJ, Gelbart T: Relationship of body iron
stores to levels of serum ferritin, serum iron, unsaturated
iron binding capacity and transferrin saturation in patients
with iron storage disease.  Acta Haematol 2002, 107:145-149.
34. Bell H, Skinningsrud A, Raknerud N, Try K: Serum ferritin and
transferrin saturation in patients with chronic alcoholic and
non-alcoholic liver diseases.  J Intern Med 1994, 236:315-322.
35. Moirand R, Lescoat G, Delamaire D, Lauvin L, Campion JP, Deugnier
Y, Brissot P: Increase in glycosylated and nonglycosylated
serum ferritin in chronic alcoholism and their evolution dur-
ing alcohol withdrawal.  Alcohol Clin Exp Res 1991, 15:963-969.
36. Southerland HLJ, Brown JE: The Federal Road through Georgia, the Creek
Nation, and Alabama, 1806-1836. Tuscaloosa, The University of Ala-
bama Press; 1989:1-198. 
37. Williams WL: Ethnic Life.  Cherokees.  In Encyclopedia of Southern
Culture Edited by: Wilson CR and Ferris W. Chapel Hill, The Univer-
sity of North Carolina Press; 1989:423-424. 
38. Paredes JA: Ethnic Life.  Creeks.  In Encyclopedia of Southern Culture
Edited by: Wilson CR and Ferris W. Chapel Hill, The University of
North Carolina Press; 1989:426. 
39. Pickett AJ: History of Alabama and Incidentally of Georgia and Mississippi,
from the Earliest Period.  1851. Volume XII.  . Clerk's Office of the Dis-
trict Court of the United States for the Middle District of Alabama.
edition. Edited by: Alabama CODCUSMD. Birmingham, Birmingham
Book and Magazine Co. (republisher); 1961:1-685. 
40. Alabama State Department of Archives and History: Alabama Cen-
sus Returns 1820 and An Abstract of Federal Census of Ala-
bama 1830.  Alabama Historical Quarterly 1944, Fall Issue:333-513.
41. U.S.Census Bureau.: 2004 [http://factfinder.census.gov].
42. U.S. Census Bureau: 2004 [http://www.census.gov/population/www/
ancestry.html].
43. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA: Prac-
tice guideline development task force of the College of
American Pathologists. Hereditary hemochromatosis.  Clin
Chim Acta 1996, 245:139-200.
44. Sheth SG, Gordon FD, Chopra S: Nonalcoholic steatohepatitis.
Ann Intern Med 1997, 126:137-145.
45. Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani
P, Taioli E, Valenti L, Fiorelli G: Hyperferritinemia, iron overload,
and multiple metabolic alterations identify patients at risk
for nonalcoholic steatohepatitis.  Am J Gastroenterol 2001,
96:2448-2455.
46. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR: Measure-
ments of iron status in patients with chronic hepatitis.  Gas-
troenterology 1992, 102:2108-2113.
47. Kowdley KV: Chronic viral hepatitis and hemochromatosis.  In
Hemochromatosis.  Genetics, pathophysiology, diagnosis and treatment
Edited by: Barton JC and Edwards CQ. Cambridge, Cambridge Uni-
versity Press; 2000:387-395. 
48. Whitfield JB, Cullen LM, Jazwinska EC, Powell LW, Heath AC, Zhu G,
Duffy DL, Martin NG: Effects of HFE C282Y and H63D poly-
morphisms and polygenic background on iron stores in a
large community sample of twins.  Am J Hum Genet 2000,
66:1246-1258.
49. Rossi E, Bulsara MK, Olynyk JK, Cullen DJ, Summerville L, Powell LW:
Effect of hemochromatosis genotype and lifestyle factors on
iron and red cell indices in a community population.  Clin Chem
2001, 47:202-208.
50. Harlow SD, Campbell B: Ethnic differences in the duration and
amount of menstrual bleeding during the postmenarcheal
period.  Am J Epidemiol 1996, 144:980-988.
51. Borwein ST, Ghent CN, Flanagan PR, Chamberlain MJ, Valberg LS:
Genetic and phenotypic expression of hemochromatosis in
Canadians.  Clin Invest Med 1983, 6:171-179.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2350/7/22/prepub